Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vital Therapies, Inc.

TRADE

NASDAQ: VTLHealthcare / Biotechnology / USA
0.43+0.18+72.00%Vol 49 905 8341Y Perf -91.06%
Sep 18th, 2018 16:00
BID0.43 ASK0.44
Open0.26 Previous Close0.25
Pre-Market0.28 After-Trading0.42
 0.03 12.00%  -0.01 -2.33%
Target Price
7.25 
Analyst Rating
Hold 3.00
Potencial %
1 586.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/67 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/97 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Sell
Price Range Ratio 52wk %
1.89 
Earnings Date
24th Oct 2018

Today's Price Range

0.260.47

 

52wk Range

0.259.75

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-97.22%
3 Months
-95.76%
6 Months
-95.80%
1 Year
-91.06%
3 Years
-93.81%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTL0.430.180072.00
AAPL218.240.36000.17
GOOG1 161.225.17000.45
MSFT113.211.07000.95
XOM83.630.22000.26
WFC54.500.19000.35
JNJ140.540.58000.41
FB160.30-0.2800-0.17
GE12.66-0.0400-0.31
JPM114.300.46000.40
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.70
Current Ratio 3.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.56
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.30
Cash Flow Per Share -1.06
Price to Tangible Book0.56
Book Value per Share0.62
Enterprise Value (in ths.)-16 287
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-112.14
ROE last 12 Months -108.51
Return on Assets (5Y Avg) -83.47
ROA last 12 Months -93.77
Return on Capital (5Y Avg) -105.38
ROC last 12 Months -109.94
Return on invested Capital Q -40.29
Return on invested Capital Y-97.20
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.33-0.309.09
Q01 2018-0.34-0.340.00
Q04 2017-0.30-0.35-16.67
Q03 2017-0.30-0.300.00
Q02 2017-0.30-0.293.33
Q01 2017-0.37-0.39-5.41
Q04 2016-0.33-0.37-12.12
Q03 2016-0.32-0.320.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.33-3.13Negative
9/2018 QR-0.29-3.57Negative
12/2018 FY-1.233.15Positive
12/2019 FY-1.3012.75Positive
Next Report Date24th Oct 2018
Estimated EPS Next Report-0.25
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume49 905 834
Shares Outstanding (in ths.)42 370
Trades Count38 919
Dollar Volume17 482 982
Avg. Volume1 030 618
Avg. Weekly Volume27 750 170
Avg. Monthly Volume7 269 667
Avg. Quarterly Volume2 513 812

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

75%25%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (50.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
1 (50.00 %)
1 (50.00 %)
Hold
3 (100.00 %)
0 (0.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Strong Buy
1.50
Moderate Buy
2.50

There are no comments yet.

News

x